Integrins in thyroid tissue: upregulation of a2b1 in anaplastic thyroid carcinoma

Objective: To evaluate the integrin pattern in the normal thyroid gland and in different pathological disorders including malignant tumors, because the aggressiveness of several malignant tumors correlates with alterations in the expression of one or more integrins. Design: We examined the expression of integrins and E-cadherin immunohistochemically in a large and well-defined sample of normal and pathological human thyroid tissue. Methods: Cryosections of 58 thyroid tissue specimens from normal tissue, thyrotoxicosis, nodular goiter, oxyphilic adenoma, follicular adenoma, follicular carcinoma, papillary carcinoma and ana-plastic carcinoma, and three lymph node metastases were investigated immunohistochemically using monoclonal antibodies specifically recognizing the integrin b1-, b4-, a1-, a2-, a3-, a5- and a6-subunits, or E-cadherin. Results: All thyroid epithelial cells expressed integrin b1- and a3-subunits. Immunostaining of the b4-subunit and the a6-subunits was found only in tumors. The staining pattern in the three lymph node metastases from papillary carcinomas did not differ from that in their primaries. Anaplastic carcinomas demonstrated neoexpression of the integrin a2-subunit. E-cadherin was detected in all tissues except anaplastic carcinomas. Conclusions: Neoexpression of a6b4 was seen in most malignant tumors, whereas a2 was exclusively found in anaplastic carcinomas. In the latter, a loss of E-cadherin expression was also seen. These changes in cell adhesion molecule expression strongly suggest an association with the acquisition of proliferative and invasive properties. European Journal of Endocrinology 138 104–11